Europe PMCopen access
Recent advances in HER2-targeted inhibitors for cancer therapy
Resistance, Selectivity, clinical study, Her2 Inhibitors, Ex20ins Mutation
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 478493
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.